 |
Osteoporosis, cardiovascular disease, hot flashes and mood swings can all result from
the onset of menopause and the corresponding drop of estrogen levels. Osteoporosis is
also a concern for men as they grow older. Every 5% decrease in bone density increases
the risk of fracture by 40%. Ultra Osteo Support's unique combination of nutrients acts
to combat bone loss and increase bone density by providing calcium in its most
readily absorbed form.
| Clinical Indications
|
Contraindications
|
Actives
- Ipriflavone (decreases bone loss, maintains or increases bone density)
- Calcium-MCHC [Microcrystalline hydroxyapatite compound]
(well-absorbed, without the disadvantages of other calcium forms; restores bone)
- Calcium Citrate (promotes hyper-absorption of calcium)
- Boron (promotes increased levels of estrogen, leading to reduced urinary
excretion of calcium, magnesium, and phosphorous)
- Magnesium (aids in calcium absorption and utilization;
reduces muscle spasms and cramps)
- Copper (helps low bone turnover; helps construct the
protein matrix that builds bone)
- Vitamin K1 [phylloquinone] (increases bone density in women with
vertebral compression fracture due to osteoporosis; increases bone
formation in post-menopausal women)
- Silicon (aids in the formation of collagen in bone, cartilage
and other connective tissues)
Drug Interactions
For further detailed information including ingredient levels, dosages and
supporting studies download the Ultra Osteo Support product sheet in .pdf format.
|